The global NGS informatics and clinical genomics market is expected to grow from USD 1.5 billion in 2018 to USD 2.8 billion by 2030, at a CAGR of 12.2% during the forecast period. The major factors driving the growth of this market are increasing adoption of NGS for research and development, growing demand for personalized medicine, and increasing number of clinical trials using NGS technology.
The global NGS informatics and clinical genomics market is segmented on the basis of type into LIMS, data analysis tools, interpretation tools, storage solutions, computing solutions; on the basis of application into academic and research institutes (ARIs), biopharmaceutical industry (BPI), diagnostic industry (DIA), government agencies (GA), hospitals and clinics (H&C); on the basis of region into North America (NA), Latin America (LA), Europe(EU) Asia Pacific & Middle East & Africa(APMEA).
- The market for NGS Informatics and Clinical Genomics is expected to reach $3,814 million by 2022.
- Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and obesity are driving the growth of the market for NGS Informatics and Clinical Genomics.
- Increasing adoption of personalized medicine in developed countries such as US, Japan, Germany etc, is also driving the growth of the market for NGS Informatics and Clinical Genomics.
- Increasing investments in research & development activities by key players in this industry are also driving the growth of this market.
Industry Growth Insights published a new data on “NGS Informatics and Clinical Genomics Market”. The research report is titled “NGS Informatics and Clinical Genomics Market research by Types (LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions), By Applications (Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics), By Players/Companies 2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN, SOPHiA GENETICS”.
Scope Of The Report
Report Attributes
Report Details
Report Title
NGS Informatics and Clinical Genomics Market Research Report
By Type
LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions
By Application
Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics
By Companies
2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN, SOPHiA GENETICS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global NGS Informatics and Clinical Genomics Market Report Segments:
The global NGS Informatics and Clinical Genomics market is segmented on the basis of:
Types
LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 2bPrecise
- Epic Systems
- Flatiron Health
- GenomOncology
- Illumina
- IBM
- Koninklijke Philips
- QIAGEN
- SOPHiA GENETICS
Highlights of The NGS Informatics and Clinical Genomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- LIMS
- Data Analysis
- Interpretation Tools
- Storage
- Computing Solutions
- By Application:
- Academics and Research Institutes
- Biopharmaceutical Industry
- Diagnostic Industry
- Government Agencies
- Hospitals and Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NGS Informatics and Clinical Genomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NGS informatics and clinical genomics is the application of genomic technologies to healthcare delivery, research, and patient care. NGS technologies are used to identify genetic variants that may be associated with diseases or health conditions. Clinical genomics uses genomic data from patients to improve diagnosis and treatment of disease.
Some of the major players in the ngs informatics and clinical genomics market are 2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN, SOPHiA GENETICS.
The ngs informatics and clinical genomics market is expected to grow at a compound annual growth rate of 12.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. NGS Informatics and Clinical Genomics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. NGS Informatics and Clinical Genomics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. NGS Informatics and Clinical Genomics Market - Supply Chain
4.5. Global NGS Informatics and Clinical Genomics Market Forecast
4.5.1. NGS Informatics and Clinical Genomics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. NGS Informatics and Clinical Genomics Market Size (000 Units) and Y-o-Y Growth
4.5.3. NGS Informatics and Clinical Genomics Market Absolute $ Opportunity
5. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
5.3.1. LIMS
5.3.2. Data Analysis
5.3.3. Interpretation Tools
5.3.4. Storage
5.3.5. Computing Solutions
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
6.3.1. Academics and Research Institutes
6.3.2. Biopharmaceutical Industry
6.3.3. Diagnostic Industry
6.3.4. Government Agencies
6.3.5. Hospitals and Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029
9. North America NGS Informatics and Clinical Genomics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
9.4.1. Academics and Research Institutes
9.4.2. Biopharmaceutical Industry
9.4.3. Diagnostic Industry
9.4.4. Government Agencies
9.4.5. Hospitals and Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
9.7.1. LIMS
9.7.2. Data Analysis
9.7.3. Interpretation Tools
9.7.4. Storage
9.7.5. Computing Solutions
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029
10. Latin America NGS Informatics and Clinical Genomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
10.4.1. Academics and Research Institutes
10.4.2. Biopharmaceutical Industry
10.4.3. Diagnostic Industry
10.4.4. Government Agencies
10.4.5. Hospitals and Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
10.7.1. LIMS
10.7.2. Data Analysis
10.7.3. Interpretation Tools
10.7.4. Storage
10.7.5. Computing Solutions
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029
11. Europe NGS Informatics and Clinical Genomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
11.4.1. Academics and Research Institutes
11.4.2. Biopharmaceutical Industry
11.4.3. Diagnostic Industry
11.4.4. Government Agencies
11.4.5. Hospitals and Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
11.7.1. LIMS
11.7.2. Data Analysis
11.7.3. Interpretation Tools
11.7.4. Storage
11.7.5. Computing Solutions
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe NGS Informatics and Clinical Genomics Demand Share, 2019-2029
12. Asia Pacific NGS Informatics and Clinical Genomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
12.4.1. Academics and Research Institutes
12.4.2. Biopharmaceutical Industry
12.4.3. Diagnostic Industry
12.4.4. Government Agencies
12.4.5. Hospitals and Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
12.7.1. LIMS
12.7.2. Data Analysis
12.7.3. Interpretation Tools
12.7.4. Storage
12.7.5. Computing Solutions
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific NGS Informatics and Clinical Genomics Demand Share, 2019-2029
13. Middle East & Africa NGS Informatics and Clinical Genomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
13.4.1. Academics and Research Institutes
13.4.2. Biopharmaceutical Industry
13.4.3. Diagnostic Industry
13.4.4. Government Agencies
13.4.5. Hospitals and Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
13.7.1. LIMS
13.7.2. Data Analysis
13.7.3. Interpretation Tools
13.7.4. Storage
13.7.5. Computing Solutions
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa NGS Informatics and Clinical Genomics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global NGS Informatics and Clinical Genomics Market: Market Share Analysis
14.2. NGS Informatics and Clinical Genomics Distributors and Customers
14.3. NGS Informatics and Clinical Genomics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 2bPrecise
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Epic Systems
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Flatiron Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GenomOncology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Illumina
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. IBM
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Koninklijke Philips
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. QIAGEN
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SOPHiA GENETICS
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. F
